Rotimi C, Cooper R, Ogunbiyi O, Morrison L, Ladipo M, Tewksbury D, Ward R
Department of Preventive Medicine and Epidemiology, Loyola University, Chicago, Ill, USA.
Circulation. 1997 May 20;95(10):2348-50. doi: 10.1161/01.cir.95.10.2348.
We evaluated the association among the M235T and T174M variants of the angiotensinogen (AGT) gene, plasma AGT, and hypertension status in a sample of Nigerians.
Participants were selected from the extremes of the blood pressure distribution obtained from the population survey of 2509 men and women aged 25 to 74 years. Cases (hypertensive subjects) were individuals who had high blood pressure or were taking antihypertensive medication, and control subjects were individuals with low blood pressure who had never taken antihypertensive medication. We found a significant association between the M235T variant and plasma AGT level. Hypertensive subjects had higher plasma AGT levels compared with control subjects. The allele frequencies of the two variants were similar in the hypertensive patients and the control subjects.
The consistent relationships observed between the M235T variant and the protein product and between plasma level of the protein and hypertension status in different ethnic groups provide some evidence for a biochemical mechanism linking DNA variation in the renin-angiotensin system with the hypertension phenotype.
我们在一组尼日利亚人群样本中评估血管紧张素原(AGT)基因的M235T和T174M变异、血浆AGT水平与高血压状态之间的关联。
参与者选自2509名年龄在25至74岁的男性和女性人群调查中血压分布的两端。病例(高血压患者)为患有高血压或正在服用抗高血压药物的个体,对照受试者为血压低且从未服用过抗高血压药物的个体。我们发现M235T变异与血浆AGT水平之间存在显著关联。与对照受试者相比,高血压患者的血浆AGT水平更高。这两种变异的等位基因频率在高血压患者和对照受试者中相似。
在不同种族群体中观察到的M235T变异与蛋白质产物之间以及蛋白质血浆水平与高血压状态之间的一致关系,为肾素 - 血管紧张素系统中的DNA变异与高血压表型之间的生化机制提供了一些证据。